Severe COVID-19

15 registered clinical trials studyying Severe COVID-19 — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	Risk Identification of Long-term Complications NCT06235866	Wuhan Central Hospital	—
Completed	Effect of Traditional Chinese Medicine of Severe COVID-19 NCT06714032	Henan University of Traditional Chinese Medicine	Phase 3
Terminated	Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired NCT05254990	Dompé Farmaceutici S.p.A	Phase 3
Recruiting	Impact of Post-ARDS Covid-19 Sedation on Persistent Neuroinflammation NCT05233605	Assistance Publique - Hôpitaux de Paris	—
Unknown	COVID-19 and VA-LRTI: Second Versus First Wave of the Pandemic NCT05256511	University Hospital, Lille	—
Unknown	Generation of SARS-CoV-2-specific T Lymphocytes From Recovered Donors and Administration to High-risk COVID-19 NCT05447013	George Papanicolaou Hospital	Phase 1 / Phase 2
Unknown	Therapeutic Plasma Exchange as an Adjunctive Strategy to Treat Coagulopathy and Inflammation in Severe Covid-1 NCT04613986	University of Zurich	N/A
Completed	Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study) NCT04866082	Brno University Hospital	—
Unknown	Corticosteroids in Severe COVID-19(ASAP-C Study) NCT04648410	Brno University Hospital	—
Terminated	Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients NCT04713176	Daewoong Pharmaceutical Co. LTD.	Phase 3
Completed	A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With COVID-19 NCT04733833	Vascular Biogenics Ltd. operating as VBL Therapeutics	Phase 2
Unknown	Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-1 NCT04712344	University of Erlangen-Nürnberg Medical School	Phase 2
Completed	Oral Probiotics and Secondary Bacterial Pneumonia in Severe COVID-19 NCT05175833	Universidade de Passo Fundo	Phase 2
Unknown	Comparative Analysis of Clinical Parameters and Radiographic Changes of Severe COVID-19 NCT04918901	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Completed	Safety and Efficacy of Medications COVID-19 NCT05596617	Hospital San Carlos, Madrid	N/A